Weiss Amir, Chief Accounting Officer at Teva Pharmaceutical Industries Ltd. ($TEVA), sold shares on the open market twice in the last year, totaling about $672 thousand. His most recent sale occurred on December 16, 2025. These sales rank 5,838th among 11,678 insiders in our database, where the average is 8.6 million per person across 6.4 transactions. Amir made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 3537 | $0.00 | 10,613.0000 | 1,163,000,000 | 25.00% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 3537 | $0.00 | 30,695.0000 | 1,163,000,000 | 13.02% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 5650 | $0.00 | 27,158.0000 | 1,163,000,000 | 26.27% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 10679 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 5650 | $0.00 | 11,300.0000 | 1,163,000,000 | 33.33% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | A | Restricted Share Units | 11280 | $0.00 | 11,280.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 10679 | $0.00 | 21,508.0000 | 1,163,000,000 | 98.61% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 5179 | $0.00 | 5,180.0000 | 1,163,000,000 | 50.00% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 5179 | $0.00 | 10,829.0000 | 1,163,000,000 | 91.66% | 0.00% |
| Dec. 16, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | S | Ordinary Shares | 12300 | $30.20 | 5,650.0000 | 1,164,000,000 | 68.52% | 0.00% |
| Nov. 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | S | Ordinary Shares | 12300 | $24.44 | 17,950.0000 | 1,164,000,000 | 40.66% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 3566 | $0.00 | 30,250.0000 | 1,131,000,000 | 13.36% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 3566 | $0.00 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | A | Restricted Share Units | 14150 | $0.00 | 14,150.0000 | 1,131,000,000 | 9999.99% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 10676 | $0.00 | 21,034.0000 | 1,131,000,000 | 103.07% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 5650 | $0.00 | 26,684.0000 | 1,131,000,000 | 26.86% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 10676 | $0.00 | 10,679.0000 | 1,131,000,000 | 49.99% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 5650 | $0.00 | 16,950.0000 | 1,131,000,000 | 25.00% | 0.00% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 5179 | $0.00 | 10,358.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 5179 | $0.00 | 10,359.0000 | 1,131,000,000 | 33.33% | 0.00% |
| May 15, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | S | Ordinary Shares | 15500 | $16.80 | 17,814.0000 | 1,123,000,000 | 46.53% | 0.00% |
| May 16, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | S | Ordinary Shares | 12635 | $16.65 | 5,179.0000 | 1,123,000,000 | 70.93% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 3564 | $0.00 | 33,314.0000 | 1,119,000,000 | 11.98% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 3564 | $0.00 | 3,566.0000 | 1,119,000,000 | 49.99% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 10676 | $0.00 | 29,750.0000 | 1,119,000,000 | 55.97% | 0.00% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 5179 | $0.00 | 19,074.0000 | 1,119,000,000 | 37.27% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | A | Restricted Share Units | 22600 | $0.00 | 22,600.0000 | 1,119,000,000 | 9999.99% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 10676 | $0.00 | 21,355.0000 | 1,119,000,000 | 33.33% | 0.00% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 5179 | $0.00 | 15,538.0000 | 1,119,000,000 | 25.00% | 0.00% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Restricted Share Units | 3219 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | M | Ordinary Shares | 3219 | $0.00 | 13,895.0000 | 1,119,000,000 | 30.15% | 0.00% |
| Feb. 1, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Weiss Amir | Chief Accounting Officer | S | Ordinary Shares | 31766 | $12.37 | 10,676.0000 | 1,119,000,000 | 74.85% | 0.00% |